Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites. - Chalon,S.A.; Desager,J.P.; Desante,K.A.; Frye,R.F.; Witcher,J.; Long,A.J.; Sauer,J.M.; Golnez,J.L.; Smith,B.P.; Thomasson,H.R.; Horsmans,Y. (Clin Pharmacol Ther, 2003)